Breast cancer predisposition syndromes

Deborah Hemel, Susan M. Domchek

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

A small, but important, percentage of breast cancer cases is caused by the inheritance of a single copy of a mutated gene. BRCA1 and BRCA2 are the genes most commonly associated with inherited breast cancer; however, mutations in TP53 and PTEN cause Li-Fraumeni syndrome and Cowden syndrome, respectively, both of which are associated with high lifetime risks of breast cancer. Advances in the field of breast cancer genetics have led to an improved understanding of detection and prevention strategies. More recently, strategies to target the underlying genetic defects in BRCA1- and BRCA2-associated breast and ovarian cancers are emerging and may have implications for certain types of sporadic breast cancer.

Original languageEnglish (US)
Pages (from-to)799-814
Number of pages16
JournalHematology/Oncology Clinics of North America
Volume24
Issue number5
DOIs
StatePublished - Oct 2010
Externally publishedYes

Fingerprint

Breast Neoplasms
Li-Fraumeni Syndrome
Multiple Hamartoma Syndrome
BRCA2 Gene
BRCA1 Gene
Ovarian Neoplasms
Mutation
Genes

Keywords

  • BRCA1
  • BRCA2
  • Cowden Syndrome
  • Hereditary Breast and Ovarian Cancer Syndrome
  • Li Fraumeni Syndrome
  • PTEN
  • TP53

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Breast cancer predisposition syndromes. / Hemel, Deborah; Domchek, Susan M.

In: Hematology/Oncology Clinics of North America, Vol. 24, No. 5, 10.2010, p. 799-814.

Research output: Contribution to journalArticle

Hemel, Deborah ; Domchek, Susan M. / Breast cancer predisposition syndromes. In: Hematology/Oncology Clinics of North America. 2010 ; Vol. 24, No. 5. pp. 799-814.
@article{2554e4b9a0264ba5913ae1d093d4ec53,
title = "Breast cancer predisposition syndromes",
abstract = "A small, but important, percentage of breast cancer cases is caused by the inheritance of a single copy of a mutated gene. BRCA1 and BRCA2 are the genes most commonly associated with inherited breast cancer; however, mutations in TP53 and PTEN cause Li-Fraumeni syndrome and Cowden syndrome, respectively, both of which are associated with high lifetime risks of breast cancer. Advances in the field of breast cancer genetics have led to an improved understanding of detection and prevention strategies. More recently, strategies to target the underlying genetic defects in BRCA1- and BRCA2-associated breast and ovarian cancers are emerging and may have implications for certain types of sporadic breast cancer.",
keywords = "BRCA1, BRCA2, Cowden Syndrome, Hereditary Breast and Ovarian Cancer Syndrome, Li Fraumeni Syndrome, PTEN, TP53",
author = "Deborah Hemel and Domchek, {Susan M.}",
year = "2010",
month = "10",
doi = "10.1016/j.hoc.2010.06.004",
language = "English (US)",
volume = "24",
pages = "799--814",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "5",

}

TY - JOUR

T1 - Breast cancer predisposition syndromes

AU - Hemel, Deborah

AU - Domchek, Susan M.

PY - 2010/10

Y1 - 2010/10

N2 - A small, but important, percentage of breast cancer cases is caused by the inheritance of a single copy of a mutated gene. BRCA1 and BRCA2 are the genes most commonly associated with inherited breast cancer; however, mutations in TP53 and PTEN cause Li-Fraumeni syndrome and Cowden syndrome, respectively, both of which are associated with high lifetime risks of breast cancer. Advances in the field of breast cancer genetics have led to an improved understanding of detection and prevention strategies. More recently, strategies to target the underlying genetic defects in BRCA1- and BRCA2-associated breast and ovarian cancers are emerging and may have implications for certain types of sporadic breast cancer.

AB - A small, but important, percentage of breast cancer cases is caused by the inheritance of a single copy of a mutated gene. BRCA1 and BRCA2 are the genes most commonly associated with inherited breast cancer; however, mutations in TP53 and PTEN cause Li-Fraumeni syndrome and Cowden syndrome, respectively, both of which are associated with high lifetime risks of breast cancer. Advances in the field of breast cancer genetics have led to an improved understanding of detection and prevention strategies. More recently, strategies to target the underlying genetic defects in BRCA1- and BRCA2-associated breast and ovarian cancers are emerging and may have implications for certain types of sporadic breast cancer.

KW - BRCA1

KW - BRCA2

KW - Cowden Syndrome

KW - Hereditary Breast and Ovarian Cancer Syndrome

KW - Li Fraumeni Syndrome

KW - PTEN

KW - TP53

UR - http://www.scopus.com/inward/record.url?scp=77956324506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956324506&partnerID=8YFLogxK

U2 - 10.1016/j.hoc.2010.06.004

DO - 10.1016/j.hoc.2010.06.004

M3 - Article

VL - 24

SP - 799

EP - 814

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 5

ER -